-
公开(公告)号:US11623925B2
公开(公告)日:2023-04-11
申请号:US17873966
申请日:2022-07-26
申请人: YUHAN CORPORATION
发明人: Ja-Heouk Khoo , Doo-Byung Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin
IPC分类号: C07D403/04 , C07D239/47
摘要: The present invention provides a novel process for preparing a diaminopyrimidine derivative or acid addition salt thereof having an activity as a 5-HT4 receptor agonist. And also, the present invention provides novel crystalline forms of a hydrochloride of the diaminopyrimidine derivative and processes for preparing the same.
-
公开(公告)号:US20220281861A1
公开(公告)日:2022-09-08
申请号:US17704718
申请日:2022-03-25
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US11434224B2
公开(公告)日:2022-09-06
申请号:US17056557
申请日:2019-05-16
申请人: YUHAN CORPORATION
发明人: Ja-Heouk Khoo , Doo-Byung Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin
IPC分类号: C07D403/04 , C07D239/47
摘要: Provided are a novel process for preparing a diaminopyrimidine derivative or acid addition salt thereof having an activity as a 5-HT4 receptor agonist, crystalline forms of a hydrochloride of the diaminopyrimidine derivative, and processes for preparing the same.
-
公开(公告)号:US11708362B2
公开(公告)日:2023-07-25
申请号:US17704718
申请日:2022-03-25
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
CPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US20230312545A1
公开(公告)日:2023-10-05
申请号:US18328267
申请日:2023-06-02
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
CPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additionally, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US20210269427A1
公开(公告)日:2021-09-02
申请号:US17115037
申请日:2020-12-08
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US10858353B2
公开(公告)日:2020-12-08
申请号:US16633695
申请日:2018-07-25
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Doo-Byung Lee , Jung-Ae Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin , Sang-Seol Jeon
IPC分类号: C07D413/14 , C07D265/32 , C07D403/10
摘要: The present invention provides a novel process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US11286253B2
公开(公告)日:2022-03-29
申请号:US17115037
申请日:2020-12-08
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US11198684B2
公开(公告)日:2021-12-14
申请号:US16633756
申请日:2018-07-25
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Doo-Byung Lee , Jung-Ae Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin , Sang-Seol Jeon
IPC分类号: C07D265/30 , C07D295/135 , C07D403/04 , C07D413/14
摘要: The present invention provides intermediates useful for the synthesis of an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors; and processes for preparing the same. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US10889578B2
公开(公告)日:2021-01-12
申请号:US16633684
申请日:2018-07-25
申请人: Yuhan Corporation
发明人: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC分类号: C07D413/14
摘要: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
-
-
-
-
-
-
-
-